Exploring Emotion and Emotional Variability as Digital Biomarkers in Frontotemporal Dementia Speech

Frontotemporal Dementia (FTD) encompasses a range of progressive neurodegenerative conditions that impair speech production and comprehension, higher cognitive functions, behavior, and motor skills. Considerable research has focused on conventional acoustic speech markers in FTD, as well as assessments of apathy and challenges in emotion recognition and expression.

In this study, Redenlab has collaborated with the University of Melbourne, Monash University, and the Massachusetts Institute of Technology.

For more information about the study, please click here.

Related Post

  • Posted on 26 March, 2025
    A recent study published in iScience explores the effects of KAT6B overexpression in mice, shedding light on the behavioral implications...
    • Posted on 18 February, 2025
      Batten disease, or neuronal ceroid lipofuscinosis (NCL), is a devastating childhood dementia that causes progressive loss of speech, language, and...
      • Posted on 18 February, 2025
        Redenlab is dedicated to advancing research in the field of speech, language, and cognitive disorders, particularly in the context of...